198 related articles for article (PubMed ID: 33929864)
1. A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
Lin Y; Zhu J; Pan L; Zhang J; Tan Z; Olivares J; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2021 Jun; 20(6):3278-3289. PubMed ID: 33929864
[TBL] [Abstract][Full Text] [Related]
2. A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
Lin Y; Zhang J; Arroyo A; Singal AG; Parikh ND; Lubman DM
Front Oncol; 2022; 12():818001. PubMed ID: 35372033
[TBL] [Abstract][Full Text] [Related]
3. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
[TBL] [Abstract][Full Text] [Related]
4. Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer's Disease Using LC-HCD-PRM-MS.
Pan L; Lin Y; Zhu J; Zhang J; Tan Z; Lubman DM
J Proteomics Bioinform; 2022; 15(5):. PubMed ID: 37362028
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS.
Tan Y; Zhu J; Gutierrez Reyes CD; Lin Y; Tan Z; Wu Z; Zhang J; Cano A; Verschleisser S; Mechref Y; Singal AG; Parikh ND; Lubman DM
ACS Omega; 2023 Apr; 8(13):12467-12480. PubMed ID: 37033807
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.
Lin Y; Zhu J; Zhang J; Dai J; Liu S; Arroyo A; Rose M; Singal AG; Parikh ND; Lubman DM
ACS Omega; 2022 Jul; 7(26):22850-22860. PubMed ID: 35811936
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of α-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS.
Yin H; Zhu J; Wang M; Yao ZP; Lubman DM
Anal Chem; 2020 Jun; 92(12):8201-8208. PubMed ID: 32426967
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
9. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
Best J; Bechmann LP; Sowa JP; Sydor S; Dechêne A; Pflanz K; Bedreli S; Schotten C; Geier A; Berg T; Fischer J; Vogel A; Bantel H; Weinmann A; Schattenberg JM; Huber Y; Wege H; von Felden J; Schulze K; Bettinger D; Thimme R; Sinner F; Schütte K; Weiss KH; Toyoda H; Yasuda S; Kumada T; Berhane S; Wichert M; Heider D; Gerken G; Johnson P; Canbay A
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):728-735.e4. PubMed ID: 31712073
[TBL] [Abstract][Full Text] [Related]
10. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
[TBL] [Abstract][Full Text] [Related]
11. PRM-MS Quantitative Analysis of Isomeric
Gutierrez Reyes CD; Huang Y; Atashi M; Zhang J; Zhu J; Liu S; Parikh ND; Singal AG; Dai J; Lubman DM; Mechref Y
Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436504
[TBL] [Abstract][Full Text] [Related]
12. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies.
Liang J; Zhu J; Wang M; Singal AG; Odewole M; Kagan S; Renteria V; Liu S; Parikh ND; Lubman DM
Sci Rep; 2019 Aug; 9(1):11580. PubMed ID: 31399619
[TBL] [Abstract][Full Text] [Related]
14. Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Ramachandran P; Xu G; Huang HH; Rice R; Zhou B; Lindpaintner K; Serie D
J Proteome Res; 2022 Apr; 21(4):1083-1094. PubMed ID: 35286803
[TBL] [Abstract][Full Text] [Related]
15. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
Hwang A; Shi C; Zhu E; Naaz F; Zhou P; Rasheed Z; Liu M; Jung LS; Duan B; Li J; Jiang K; Paka L; Gadhiya SV; Dana D; Ali Q; Yamin MA; Goldberg ID; Narayan P
PLoS One; 2018; 13(6):e0198937. PubMed ID: 29944670
[TBL] [Abstract][Full Text] [Related]
16. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.
Koyama N; Yamazaki T; Kanetsuki Y; Hirota J; Asai T; Mitsumoto Y; Mizuno M; Shima T; Kanbara Y; Arai S; Miyazaki T; Okanoue T
J Gastroenterol; 2018 Jun; 53(6):770-779. PubMed ID: 29086016
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
18. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.
Kohansal-Nodehi M; Swiatek-de Lange M; Kroeniger K; Rolny V; Tabarés G; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Chan HL; Busskamp H
Front Oncol; 2023; 13():1213898. PubMed ID: 37920152
[TBL] [Abstract][Full Text] [Related]
20. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
